CMS Participation Deadlines: March 1 & March 6, 2026
March 1st, 2026: Deadline to submit written comments to CMS for the Medicare Drug Price Negotiation Program
March 6th, 2026: Deadline to registration for CMS Roundtable Events and Townhall Meeting participation.
See below for the full registration and participation timeline as well as the drugs selected for negotiation.
Deadline: March 1, 2026 to Submit Written Comments
CMS encourages patients and caregivers to submit written input describing their real-world experience with selected medications. CMS is seeking insight into how these treatments affect daily life, health stability, unmet medical needs, and what happens when access changes or alternatives are considered. Personal experience — including how a medication works for you, how it supports independence, and how treatment disruptions affect you or your loved one — is an important part of the review process.
Written statements must be submitted through the official CMS portal no later than March 1, 2026. Late submissions will not be considered.
Patients and caregivers do not need to submit medical records or formal research. CMS is seeking clear, real-world insight into how these medications affect daily life, treatment stability, and access to care.
Register Now for a Roundtable Event
DEADLINE: March 6, 2026
The roundtable events will be held April 6 – April 17, 2026. Registration closes on March 6, 2026.
Monday, April 6
- Anoro Ellipta | (Respiratory): 11 a.m. – 1 p.m. ET | Register Now
- Biktarvy | (HIV): 2:30 – 4:30 p.m. ET | Register Now
Wednesday, April 8
- Botox; Botox Cosmetic | (Neurology/Aesthetics): 11 a.m. – 1 p.m. ET | Register Now
- Cimzia | (Rheumatology/Autoimmune): 2:30 – 4:30 p.m. ET | Register Now
Thursday, April 9
- Cosentyx | (Rheumatology/Autoimmune): 11 a.m. – 1 p.m. ET | Register Now
- Entyvio | (Rheumatology/Autoimmune): 2:30 – 4:30 p.m. ET | Register Now
Friday, April 10
- Erleada | (Oncology-Prostate): 12 – 2 p.m. ET | Register Now
Monday, April 13
- Kisqali | (Oncology-Breast): 11 a.m. – 1 p.m. ET | Register Now
- Lenvima | (Oncology-Thyroid): 2:30 – 4:30 p.m. ET | Register Now
Tuesday, April 14
- Orencia (Rheumatology/Autoimmune): 11 a.m. – 1 p.m. ET | Register Now
- Rexulti | (Mental Health): 2:30 – 4:30 p.m. ET | Register Now
Wednesday, April 15
- Trulicity | (Diabetes): 11 a.m. – 1 p.m. ET | Register Now
- Verzenio | (Oncology-Breast): 2:30 – 4:30 p.m. ET | Register Now
Thursday, April 16
- Xeljanz; Xeljanz XR (Rheumatology/Autoimmune): 11 a.m. – 1 p.m. ET | Register Now
- Xolair | (Respiratory): 2:30 – 4:30 p.m. ET | Register Now
Friday, April 17
- Tradjenta | (Diabetes): 12 – 2 p.m. ET | Register Now
Learn How Patient Voices Fit into the Negotiation Process
Medicare drug price negotiations are happening now—and patient experience evidence is required by law. Our upcoming patient-focused webinars walk you through what’s happening, what’s at stake, and how to share your story in a way CMS must consider.
